Man Group’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,227
Closed -$240K 2207
2025
Q2
$240K Sell
13,227
-4,725
-26% -$62.3K ﹤0.01% 2016
2025
Q1
$172K Sell
17,952
-1,615
-8% -$21.1K ﹤0.01% 2052
2024
Q4
$309K Buy
+19,567
New +$315K ﹤0.01% 1778
2021
Q2
Sell
-4,150
Closed -$229K 1951
2021
Q1
$229K Sell
4,150
-9,761
-70% -$647K ﹤0.01% 1713
2020
Q4
$1.01M Buy
13,911
+8,809
+173% +$1.03M ﹤0.01% 1414
2020
Q3
$1.01M Buy
5,102
+1,691
+50% +$426K ﹤0.01% 1369
2020
Q2
$954K Sell
3,411
-158
-4% -$36.9K ﹤0.01% 1288
2020
Q1
$635K Sell
3,569
-167
-4% -$35.8K ﹤0.01% 1225
2019
Q4
$917K Buy
+3,736
New +$688K ﹤0.01% 1508
2019
Q2
Sell
-6,352
Closed -$1.5M 1879
2019
Q1
$1.5M Buy
6,352
+3,127
+97% +$792K 0.01% 1447
2018
Q4
$875K Buy
3,225
+221
+7% +$63.9K ﹤0.01% 1491
2018
Q3
$1.34M Buy
3,004
+492
+20% +$230K ﹤0.01% 1556
2018
Q2
$1.18M Buy
+2,512
New +$1.33M ﹤0.01% 1557

Other funds holding ASMB

Man Group's ASMB Position: Q3 2025 in Review

Man Group sold out of Assembly Biosciences (ASMB) in Q3 2025, closing a stake of 13,227 shares — an estimated $240K sold.

Man Group first reported a position in ASMB in Q2 2018 and held it in 13 quarters. The position peaked at $1.5M in Q1 2019. 57 funds tracked by Wall St. Rank hold ASMB as of Q3 2025.

  • Man Group reported no remaining Assembly Biosciences position as of Q3 2025 after selling out during the quarter.
  • Man Group sold 13,227 Assembly Biosciences shares in Q3 2025, an estimated $240K.
  • Man Group first reported a position in Assembly Biosciences in Q2 2018 and held it in 13 quarters.
  • Man Group's Assembly Biosciences position peaked at $1.5M in Q1 2019.
  • 57 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2025.

Based on Man Group's 13F filing for Q3 2025, filed 14 Nov 2025.